| CTOR Stock | | | 0.94 0.06 6.00% |
Citius Oncology, financial statements provide useful quarterly and yearly information to potential Citius Oncology, investors about the company's current and past financial position, as well as its overall
management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Citius Oncology, financial statements helps investors assess Citius Oncology,'s valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Citius Oncology,'s valuation are summarized below:
Citius Oncology, does not presently have any fundamental signals for analysis.
Check out the analysis of
Citius Oncology, Correlation against competitors.
To learn how to invest in Citius Stock, please use our
How to Invest in Citius Oncology, guide.
Citius Oncology, Balance Sheet | | |
|
Citius Oncology, Income Statement | | |
|
Citius Oncology, Cash Flow Statement | | |
|
Citius Fundamental Market Drivers
| Shares Short Prior Month | 10.6 K |
About Citius Oncology, Financial Statements
Citius Oncology, shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Citius Oncology, investors may analyze each financial statement separately, they are all interrelated. The changes in Citius Oncology,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on Citius Oncology,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our
fundamental analysis page.
| | Last Reported | Projected for Next Year |
Pair Trading with Citius Oncology,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Citius Oncology, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Citius Oncology, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Citius Oncology, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Citius Oncology, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Citius Oncology, to buy it.
The correlation of Citius Oncology, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Citius Oncology, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Citius Oncology, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Citius Oncology, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Additional Tools for Citius Stock Analysis
When running Citius Oncology,'s price analysis, check to
measure Citius Oncology,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Oncology, is operating at the current time. Most of Citius Oncology,'s value examination focuses on studying past and present price action to
predict the probability of Citius Oncology,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Oncology,'s price. Additionally, you may evaluate how the addition of Citius Oncology, to your portfolios can decrease your overall portfolio volatility.